Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

AD/PD 2023

Browse Popular Uploads...

View all
4:51
European task force recommendations: shifting memory clinics towards prevention
Giovanni Frisoni • 30 Mar 2023
2:34
Assessing clinical meaningfulness with ‘time saved’ in Alzheimer’s disease
Suzanne Hendrix • 21 Mar 2023
2:48
TRAILBLAZER-ALZ 4: direct comparison of donanemab and aducanumab
Stephen Salloway • 19 Apr 2023
3:23
How does TPS work in Alzheimer’s disease?
Lars Wojtecki • 23 Mar 2023

Biomarker Breakthroughs

View all
2:10
Streamlining dementia diagnosis with digital biomarkers
M. Florencia Iulita • 28 Mar 2023
2:44
CSF synaptic markers in Alzheimer’s disease
Andrea Pilotto • 23 Mar 2023
4:41
Decreased kidney function associated with increased plasma p-tau levels
Bruna Bellaver • 24 Mar 2023
2:39
Detecting retinal Aβ: a promising path for non-invasive Alzheimer’s disease diagnosis
Mourad Tayebi • 30 Mar 2023

Novel Treatment Updates

View all
4:23
Phase II trial of AR1001 as a potential treatment for Alzheimer’s disease
David Greeley • 28 Mar 2023
1:50
Safety results of the Phase III gantenerumab GRADUATE I and II studies
Stephen Salloway • 19 Apr 2023
4:51
Improving the next generation of anti-amyloid antibodies: prioritizing selectivity with PMN310
Johanne Kaplan • 30 Mar 2023
7:55
All-in-one AAV vector for epigenome editing shows efficient APOE downregulation in vivo
Boris Kantor • 15 Mar 2023

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals